Bromelain Protects Against PTZ-Induced Glial Damage and Inflammation: An In Vitro and In Silico Study
dc.authorid | Joha, Ziad/0000-0001-8520-3760 | |
dc.contributor.author | Joha, Ziad | |
dc.contributor.author | Basgoz, Neslihan | |
dc.contributor.author | Ozgur, Aykut | |
dc.contributor.author | Taskiran, Ahmet Sevki | |
dc.date.accessioned | 2025-05-04T16:47:23Z | |
dc.date.available | 2025-05-04T16:47:23Z | |
dc.date.issued | 2025 | |
dc.department | Sivas Cumhuriyet Üniversitesi | |
dc.description.abstract | This study aimed to investigate how bromelain protects glial cells from pentylenetetrazole (PTZ)-induced damage, focusing on its anti-inflammatory effects. C6 glioma cells were treated with PTZ, bromelain, or a combination of PTZ and bromelain. The interactions of bromelain with iNOS (Inducible Nitric Oxide Synthase) and COX2 (Cyclooxygenase-2) were investigated using molecular docking calculations. Cell viability was measured using the XTT (Methoxynitrosulfophenyl-Tetrazolium Carboxanilide) assay. iNOS, NO (Nitric Oxide), and COX2 levels were assessed using ELISA and immunofluorescence staining. Bromelain at 50 and 100 mu g/mL significantly increased cell viability (p < 0.001). On the other hand, bromelain at 50 g/mL reduced inflammation, as indicated by lower levels of NO, iNOS, and COX2 (p < 0.001). In-silico predictions suggest that bromelain can effectively target iNOS and COX2, key inflammatory proteins. These findings indicate that bromelain protects glial cells by exerting anti-inflammatory effects. However, further research is needed to understand the underlying mechanisms fully. | |
dc.identifier.doi | 10.1007/s12013-025-01703-8 | |
dc.identifier.issn | 1085-9195 | |
dc.identifier.issn | 1559-0283 | |
dc.identifier.pmid | 40000586 | |
dc.identifier.scopus | 2-s2.0-85218904645 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.uri | https://doi.org/10.1007/s12013-025-01703-8 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12418/35588 | |
dc.identifier.wos | WOS:001431254200001 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Humana Press Inc | |
dc.relation.ispartof | Cell Biochemistry and Biophysics | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.snmz | KA_WOS_20250504 | |
dc.subject | Bromelain | |
dc.subject | PTZ | |
dc.subject | Inflammation | |
dc.subject | Neuroprotection | |
dc.subject | Glial Cells | |
dc.title | Bromelain Protects Against PTZ-Induced Glial Damage and Inflammation: An In Vitro and In Silico Study | |
dc.type | Article |